Evidence mapPaperPMID 41828577Full record

ArticleInternational journal of molecular sciences2026

Association of Adiponectin Gene Polymorphism rs266729 in Obese People with Type Two Diabetes Mellitus in North Bulgaria's Population.

Tihomir Rashev, Stefan Trifonov

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tihomir RashevDepartment of Anatomy, Histology, Cytology and Biology, Medical University-Pleven, 5800 Pleven, Bulgaria.
Stefan TrifonovDepartment of Anatomy, Histology, Cytology and Biology, Medical University-Pleven, 5800 Pleven, Bulgaria.ORCID 0000-0002-5186-0487

Funding

Medical University - Pleven through the University Grants Commission Project No. D1/2021
6 · The paper itself

Abstract

The alarming surge in obesity rates represents a critical health concern in developed nations. This condition is associated with several health issues grouped under the term metabolic syndrome. This alarming data mandates an investigation into the causes and risk of this syndrome. One category of causes is genetic factors. The adiponectin gene has been subject to several studies exploring its single nucleotide polymorphisms, especially rs266729, across diverse populations. This study included 156 subjects. Body weight, body mass index, and blood pressure were measured, and levels of fasting plasma glucose (FPG), total cholesterol, triglycerides, HDL, and LDL were determined. Genotyping was performed. There was significant association of rs266729 polymorphism with obesity and type 2 diabetes mellitus (T2DM), with notably higher frequency of the G allele among these subjects. Additionally, the results demonstrated significant influence on the detected levels of HDL. Individuals carrying the homozygous (GG) and heterozygous (CG) genotypes exhibited a three-fold and two-fold increased risk of elevated FPG levels, respectively. There was also a significant association of these genotypes with T2DM when compared with the wild-type genotype (CC). These observations strongly indicated a potential involvement of the adiponectin gene polymorphism rs266729 in the pathogenesis of T2DM among subjects from North Bulgaria.

Indexed as

AdiponectinDiabetes Mellitus, Type 2Genetic Predisposition to DiseaseObesityPolymorphism, Single NucleotideAdultAllelesBlood GlucoseBody Mass IndexBulgariaFemaleGene FrequencyGenetic Association StudiesGenotypeHumansMaleAdiponectinADIPOQ protein, humanBlood Glucoseadiponectinobesitypolymorphismtype 2 diabetes mellitus

Identifiers

PMID41828577
PMCPMC12985942

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.